Increased response to ketamine following treatment at long intervals: Implications for intermittent use

被引:56
作者
Trujillo, Keith A. [1 ,2 ]
Zamora, Juan J. [1 ,2 ]
Warmoth, Kathleen P. [1 ,2 ]
机构
[1] Calif State Univ San Marcos, Dept Psychol, San Marcos, CA 92096 USA
[2] Calif State Univ San Marcos, Off Biomed Res & Training, San Marcos, CA USA
关键词
environment; ketamine; locomotor behavior; neuroadaptation; rave; sensitization;
D O I
10.1016/j.biopsych.2007.02.014
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Ketamine has been used for many years as a dissociative anesthetic; however, there is evidence of increasing abuse, especially at dance clubs and raves. In addition, there is increasing interest in the use of subanesthetic doses of ketamine for the treatment of pain and depression, as well as for clinical research on schizophrenia. Despite growing use, relatively little is known about the consequences of repeated administration of low doses of ketamine. Methods: To determine the changes in response to repeated administration, ketamine (20 mg/kg or 50 mg/kg intraperitoneal [IP]) was administered once weekly to laboratory rats and the locomotor response was assessed following each injection. Results: Repeated administration of ketamine led to an escalation in the stimulant effects of the drug, characteristic of behavioral sensitization. The development of sensitization was greater when ketamine was repeatedly administered in the presence of distinct environmental cues. Conclusions: Intermittent administration of ketamine at weekly intervals leads to the development of locomotor sensitization. These results suggest caution in the repeated use of ketamine for recreational or clinical purposes.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 53 条
[1]   THE DISSOCIATIVE ANESTHETICS, KETAMINE AND PHENCYCLIDINE, SELECTIVELY REDUCE EXCITATION OF CENTRAL MAMMALIAN NEURONS BY N-METHYL-ASPARTATE [J].
ANIS, NA ;
BERRY, SC ;
BURTON, NR ;
LODGE, D .
BRITISH JOURNAL OF PHARMACOLOGY, 1983, 79 (02) :565-575
[2]   Drug-induced neurobehavioral plasticity: the role of environmental context [J].
Badiani, A ;
Robinson, TE .
BEHAVIOURAL PHARMACOLOGY, 2004, 15 (5-6) :327-339
[3]   Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia [J].
Becker, A ;
Peters, B ;
Schroeder, H ;
Mann, T ;
Huether, G ;
Grecksch, G .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (04) :687-700
[4]   Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review) [J].
Bell, RF ;
Dahl, JB ;
Moore, RA ;
Kalso, E .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2005, 49 (10) :1405-1428
[5]   Is intranasal ketamine an appropriate treatment for chronic non-cancer breakthrough pain? [J].
Bell, RF ;
Kalso, E .
PAIN, 2004, 108 (1-2) :1-2
[6]   Antidepressant effects of ketamine in depressed patients [J].
Berman, RM ;
Cappiello, A ;
Anand, A ;
Oren, DA ;
Heninger, GR ;
Charney, DS ;
Krystal, JH .
BIOLOGICAL PSYCHIATRY, 2000, 47 (04) :351-354
[7]   DEVELOPMENT OF TOLERANCE TO KETAMINE IN AN INFANT UNDERGOING REPEATED ANESTHESIA [J].
BYER, DE ;
GOULD, AB .
ANESTHESIOLOGY, 1981, 54 (03) :255-256
[8]   Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study [J].
Carr, DB ;
Goudas, LC ;
Denman, WT ;
Brookoff, D ;
Staats, PS ;
Brennen, L ;
Green, G ;
Albin, R ;
Hamilton, D ;
Rogers, MC ;
Firestone, L ;
Lavin, PT ;
Mermelstein, F .
PAIN, 2004, 108 (1-2) :17-27
[9]   Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine [J].
Cho, HS ;
D'Souza, DC ;
Gueorguieva, R ;
Perry, EB ;
Madonick, S ;
Karper, LP ;
Abi-Dargham, A ;
Belger, A ;
Abi-Saab, W ;
Lipschitz, D ;
Bennet, A ;
Seibyl, JP ;
Krystal, JH .
PSYCHOPHARMACOLOGY, 2005, 179 (01) :136-143
[10]   The health and psycho-social consequences of ketamine use [J].
Copeland, J ;
Dillon, P .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2005, 16 (02) :122-131